On Call with Dr. Mary Talley Bowden

Transparency, informed consent, and patient empowerment
  • 5.0 (2)
  • Health & Fitness
  • Updated Semiweekly

In-depth interviews with whistleblowers, frontline physicians, veterans, and health freedom advocates who challenge mainstream medical narratives. Episodes explore vaccine safety, bodily autonomy, decentralized healthcare, and critiques of corporate medicine, often drawing from Dr. Bowden's own experiences treating thousands of COVID patients successfully and her legal battles against mandates and censorship. drbowden.substack.com

  1. Aug 25

    Medication-Induced Psychosis and the Case for Safer Psychiatric Care

    Board-certified psychiatrist Dr. Joseph Witt-Doerring discusses his specialized focus on adverse reactions to psychiatric medications and safe de-prescribing, using the high-profile Lindsay Clancy case as a timely illustration. Witt-Doerring, who has worked in clinical practice, for Johnson & Johnson, and at the FDA, argues that conventional psychiatry often oversimplifies mental distress as chemical imbalances requiring indefinite drug treatment. His approach emphasizes common-sense interventions—gradual medication reduction, accountability for diet, physical activity, and lifestyle—helping many patients regain energy and motivation that long-term drugs can suppress. Witt-Doerring reports that for roughly 80 percent of cases involving anxiety, depression, or insomnia, patients can discontinue medications without major issues. More complex conditions such as bipolar disorder or schizophrenia present greater challenges, and some individuals elect to remain on treatment. He notes a growing network of clinicians, including Mark Horowitz in the UK and participants in deprescribing mentorship programs, who share this holistic orientation. The conversation centered on Lindsay Clancy, a Massachusetts mother charged with killing her three young children in early 2023. Initially, many viewed the act as pure evil warranting imprisonment. Witt-Doerring contends the medical record supports a finding of not guilty by reason of insanity due to medication-induced psychosis. After her third child, Clancy experienced postpartum depression and life stresses. Telemedicine providers prescribed Zoloft, an SSRI; she developed severe insomnia, the dose was doubled, symptoms worsened, and it was stopped. She was later placed on Prozac, then Seroquel, and eventually amitriptyline, with the dose increased the day before the tragedy. In a short period she was exposed to approximately 11 medications. Drug labels explicitly warn that antidepressants can precipitate mania and psychosis. Clancy later reported command auditory hallucinations. Collateral evidence includes text messages in which she described the drugs damaging her brain and making her feel worse, disclosure of intrusive homicidal thoughts to family weeks earlier, and forensic analysis of her computer searches for medication side effects. Family, friends, colleagues, and her nanny described her as a loving mother with no history of violence, substance abuse, or relational breakdown—the typical motives in filicide cases. The prosecution’s theories of psychopathy or “altruistic filicide” appear inconsistent with this background. Witt-Doerring highlights parallel malpractice concerns over continued antidepressant prescribing despite clear worsening. He cites legal precedents. In the Donald Schell case, a man with a prior adverse reaction to Prozac was prescribed Paxil and, within days, killed his wife, daughter, and granddaughter before taking his own life; a jury found the manufacturer liable for failure to warn. In Canada, David Carmichael killed his son while experiencing Paxil-induced delusions and was not prosecuted for murder after authorities accepted the drug-induced psychosis explanation. Witt-Doerring underscores broader risks: roughly 17 percent of Americans take SSRIs and about 5 percent are on multiple psychiatric medications. Adverse behavioral effects are more pronounced in younger patients, whose nervous systems continue maturing into the late twenties. High-risk windows include initiation, dose increases, and abrupt discontinuation. SSRI withdrawal, long minimized as mild and self-limiting, proves severe for a substantial minority—surveys indicate that around one-third cannot discontinue because of intolerable symptoms. He advocates stronger informed consent, clinician education on deprescribing, and greater attention to physical health. Obesity, ultra-processed diets, and sedentary lifestyles contribute heavily to anxiety, depression, and insomnia; treating the body improves the mind. The Clancy case, while tragic, illustrates how rapid polypharmacy and ignored warning signs can produce catastrophic outcomes and why safer, more individualized psychiatric practice is urgently needed. Follow Dr. Josef on X and visit his clinic website here. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

    Medication-Induced Psychosis and the Case for Safer Psychiatric Care

  2. Aug 22

    The Battle for Religious Exemptions

    Attorney Brian Festa of We The Patriots USA, a pro bono firm focused on medical and religious freedom cases, outlines ongoing legal battles over states’ elimination of religious exemptions to school vaccination requirements. These efforts highlight tensions between public health mandates and First Amendment protections for religious liberty, particularly in private and religious educational settings. Festa describes the case of three Amish community schools in New York, which faced fines exceeding $150,000 for continuing to accept religious exemptions after the state repealed them in 2019. New York, like California, Connecticut, and Maine, abolished such exemptions for all schools—public, private, and parochial. West Virginia effectively bars them as well. The Amish schools, operating as private religious institutions, allowed families to opt out based on sincerely held beliefs opposing vaccination. After losing at the district court and initially at the Second Circuit, the case was remanded by the Supreme Court in light of Mahmoud v. Taylor (2025), which affirmed parents’ rights to opt children out of certain school curricula on religious grounds, and related rulings extending similar principles to public health contexts. Despite this, the Second Circuit again dismissed the challenge, distinguishing vaccination mandates as less invasive of religious freedom than curricular content—a distinction Festa criticizes, noting that vaccination effects are irreversible while classroom teaching can be countered at home. We The Patriots is litigating a nearly identical case involving Milford Christian Church and its Little Eagles Preschool in Connecticut. After Connecticut eliminated religious exemptions in 2021, the preschool continued honoring them. State inspectors threatened closure unless unvaccinated children were either vaccinated or expelled. A federal lawsuit filed in 2023 reached oral argument at the Second Circuit in April; a decision is expected imminently and is likely to follow the Amish precedent. Festa anticipates an adverse ruling, after which the firm plans to petition the Supreme Court. A parallel suit was filed in July against a public school district in Turner, Maine, on behalf of an eighth-grader whose parents seek a religious exemption. These cases position the organization to challenge exemptions losses across multiple federal circuits. Festa explains the strategic focus on religious free exercise rather than a broader bodily autonomy claim. Citing Dobbs v. Jackson Women’s Health Organization, which rejected an unenumerated constitutional right to bodily autonomy in the abortion context, he noted that courts have not recognized a general right against compelled medical interventions outside narrow settings. Religious objections often center on the historical use of aborted fetal cell lines in vaccine development and testing, as well as other ingredients or manufacturing processes that conflict with faith-based principles. A Supreme Court victory could establish nationwide precedent protecting parental rights to religious opt-outs, whether limited to religious schools or applied more broadly to all educational settings. Such a ruling would endure far longer than temporary political or executive measures. Collectively, these cases represent a multi-year campaign to restore religious exemptions and affirm parental authority. Supreme Court review offers the most durable path to protecting these liberties for current and future generations, given the lasting nature of constitutional precedent. We the Patriots is a pro-bono, non-profit legal firm focusing on medical and religious freedom cases. Register for their upcoming Vaccine Safety Awareness Marathon: Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

  3. Aug 12

    OB-GYN Dr. James Thorp Reacts to Fauci's Text Messages

    Maternal-fetal medicine specialist Dr. James Thorp discussed newly revealed text messages involving Dr. Anthony Fauci and concerns about COVID shots in pregnancy. Thorp, who has long spoken out on the topic and published related research, framed the messages as evidence that officials recognized early risks yet proceeded with aggressive promotion to pregnant women. Thorp noted that pregnancy is highly sensitive to inflammation, which can disrupt embryonic development, placentation, and lead to miscarriage, fetal death, and other complications. He referenced historical disasters such as thalidomide and diethylstilbestrol as reminders of the need for caution with unstudied substances. In his view, authorities knew the vaccines were inflammatory and associated with miscarriages but withheld the information, consistent with broader patterns of downplaying vaccine signals. Thorp offered two strategic reasons for targeting pregnant women. First, women make the majority of healthcare decisions for families across the lifespan; securing their acceptance would influence broader uptake. Second, as the most vulnerable population, their vaccination would signal safety and necessity to everyone else. He described the overall effort as a public-relations campaign led by figures such as Mark Weber at HHS, involving coordination with medical organizations, hospitals, colleges, and state boards. Professionally, Thorp faced pressure after speaking out. In September 2021, the American Board of Obstetrics and Gynecology (ABOG) emailed thousands of obstetricians, warning that failure to follow official guidelines could result in loss of licensure and board certification. Thorp responded with a detailed letter citing peer-reviewed studies, VAERS analyses, and adverse outcome data. He reported no further action against him and continued annual certification. Through a FOIA request filed with his wife, attorney Maggie Thorp, they obtained records indicating financial arrangements between HHS/CDC and the American College of Obstetricians and Gynecologists (ACOG), which then influenced related societies. Thorp argued that physicians were effectively given talking points rather than independent clinical judgment. Timeline details included the December 2020 vaccine rollout, initial statements that use in pregnancy would be voluntary, rapid uptake among healthcare workers (many pregnant), and subsequent organizational endorsements by mid-2021 culminating in the ABOG threat. Pregnant women were not exempted from workplace mandates. Thorp sharply criticized the April 2021 New England Journal of Medicine paper by Shimabukuro et al. and accompanying commentary, that contradicted VAERS data suggesting an approximately 82% miscarriage rate among completed early pregnancies—similar to figures derived from Pfizer’s post-marketing report of roughly 81% among cases with known outcomes. He also highlighted high overall casualty numbers in that short Pfizer document and questioned data-handling practices such as counting vaccinated status only after 14 days. Clinically, Thorp described observing no unusual patterns in 2020 among the thousands of high-risk pregnancies he managed, followed by sharp increases after vaccine rollout: severe menstrual irregularities across age groups, infertility, later miscarriages with heavy bleeding, fetal malformations (including rare conditions like diaphragmatic hernia appearing in clusters), cervical insufficiency, placental abnormalities, growth restriction, thrombotic events, preterm delivery, and higher neonatal intensive-care admissions. Colleagues largely remained silent, he said, after seeing professional consequences for those who raised concerns. He attributed institutional compliance partly to substantial federal funding received by hospital systems under agreements that limited disclosure. Thorp has documented these issues in his book Sacrifice: How the Deadliest Vaccine in History Targeted the Most Vulnerable, with proceeds supporting vaccine-injured individuals, and has a new Christian devotional forthcoming. The interview underscores his contention that early official awareness of risks to pregnant women was subordinated to a broader vaccination campaign, with lasting clinical and institutional effects. Follow Dr. Thorp on X @jathorpmfm and drjamesthorp.com. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

    OB-GYN Dr. James Thorp Reacts to Fauci's Text Messages

  4. Aug 6

    Australian Doctor's License Suspended for Prescribing Ivermectin

    Dr. My Le Trinh, a general practitioner in Sydney with more than 27 years in practice, faced an abrupt and prolonged professional crisis beginning September 27, 2021. Until that point she had maintained a spotless professional record, but on a single day, she was notified of two complaints lodged hours apart through the same portal. One originated from a junior doctor at a hospital concerning a COVID patient Trinh had treated remotely with ivermectin; the patient’s condition worsened and was admitted. The intern later told Trinh she had acted on instructions from a superior, an associate professor and toxicologist at Westmead Hospital. The second complaint came from an individual identifying as “John Smith,” who alleged concern for a friend’s health after an ivermectin prescription and claimed Trinh was an “anti-vaxxer” promoting alternative COVID treatments online. Contact details for this complainant proved invalid. The prescription in question belonged to a family member of Trinh’s; she had left it at a pharmacy after supplies ran short, and the pharmacy later handed it to the Australian Health Practitioner Regulation Agency (AHPRA). Australian authorities had severely restricted ivermectin prescribing by general practitioners, limiting it to specialists for approved indications and citing concerns about supply for conditions such as scabies in Aboriginal communities. Hydroxychloroquine had faced earlier and stricter limits. Official guidance for diagnosed COVID patients emphasized isolation at home under daily health-officer checks, with only paracetamol recommended and pulse-oximeter monitoring; patients were directed to hospital if their condition worsened. Trinh, having researched early treatments and followed clinicians associated with groups such as the COVID Medical Network, chose to offer ivermectin-based regimens via telehealth to patients confined by health orders. Regulators treated the dual notifications as grounds for an emergency hearing, determining she posed a risk to the public and suspending her registration the same day. Nearly five years later she remains unable to practice or provide medical advice. She pursued appeals, a judicial review, and proceedings through the tribunal and higher courts, only to encounter procedural complications when arguments were altered under pressure. Concurrently the Health Care Complaints Commission investigated and prosecuted her for unsatisfactory professional conduct and professional misconduct, including failure to surrender records of 20–30 patients—records she withheld on independent legal advice that the request lacked proper authority. In mid-2025 she was found guilty at the first stage of proceedings; the second stage, concerning sanctions, remains pending while she has filed a fresh appeal and judicial review in the Supreme Court. Trinh acknowledges she could have submitted and ended the matter more quickly. She has instead continued the fight, citing the need to defend the principle that doctors may exercise clinical judgment, including legitimate off-label prescribing once recognized even by health ministers early in the pandemic. The experience has been deeply traumatic, leaving her uncertain whether she will ever return to practice. Her account illustrates the intensity of regulatory responses to early-treatment approaches in Australia, the speed with which suspension can occur, and the protracted, costly legal processes that follow when a practitioner contests the outcome. Follow Dr. Trinh on X @myletrinh123 and donate to her legal fund here. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

    Australian Doctor's License Suspended for Prescribing Ivermectin

  5. Jul 7

    A Patient’s Redemption: Breakthrough Treatment for COVID Vaccine Injuries

    Dr. Kevin McCairn and patient Ken Evans joined me to discuss a promising intervention for severe COVID-19 vaccine injuries. Conducted from Japan, where McCairn and colleagues treat patients, the conversation highlights the debilitating effects of vaccine-induced amyloid formation and a novel therapeutic approach offering dramatic recoveries. McCairn, who has treated approximately 25 patients, describes vaccine injuries linked to abnormal amyloid and mis-folded proteins, often triggered by spike protein. These cause widespread microclots, autoimmune responses, brain fog, extreme fatigue, heart irregularities, neuropathy, and organ damage. Many patients arrive after years of misdiagnosis and ineffective treatments, having spent hundreds of thousands of dollars. Evans, a former rugby player from Houston, exemplifies this struggle. Vaccinated in March 2021, he rapidly developed symptoms: skyrocketing spike antibodies (over 18,000), low B cells, liver dysfunction, endocrine chaos, autoimmune encephalitis, and malignant pericarditis visible on X-rays as a large inflamed sac around the heart. Conventional tests (cardiac MRI, stress tests) appeared normal, and doctors dismissed vaccine causation, sometimes bordering on malpractice. Thyroid removal worsened his condition. He endured ER visits with heart rates spiking to 190 bpm, fainting, blood in multiple sites, and profound brain fog that stripped him of emotion and clarity. “I was dying,” Evans recalls. “I couldn’t get out of bed.” The Japan protocol involves jugular-vein dual filtration apheresis using specialized canisters to remove autoantibodies, amyloids, and misfolded proteins directly from cerebral outflow, combined with stem cell growth factors (SGF) derived from dental pulp to promote regeneration and inhibit further clotting. Unlike peripheral vein methods, this targets neurovascular injury. Evans underwent four weeks of treatment. After the first filtration, his cognitive clarity returned. Post-second session, the pressure in his heart and panic lifted. X-rays three weeks later showed near-complete resolution of pericarditis. Spike antibodies dropped 25%, and he regained 85% function—able to laugh, parent, and live normally, though managing residual Hashimoto’s. “I have my life back,” he says. Chest X-Rays of Ken Evans before and after treatment: Many others report rapid relief from brain fog and fatigue, with spectacular turnarounds even in severe cases. Nurse Lindsay, previously housebound for years, is now able to run. Recovery is slower with extensive brain damage but generally positive. Challenges remain. Treatment costs are high, unavailable in the U.S. due to regulatory hurdles, and patients often exhaust resources first. McCairn notes emerging hydrogel-like plasma changes in samples, raising concerns about broader contamination risks. He stresses autoantibodies and molecular mimicry drive much pathology beyond persistent spike. While not a universal cure, the intervention achieves clinical significance for many. Evans’ story underscores medical gaslighting yet offers hope. As advocates push for U.S. access and recognition, this protocol demonstrates that targeted removal of pathological proteins paired with regenerative support can reverse what seemed irreversible damage. For countless injured individuals, it represents not just treatment, but restored humanity. If you are interested in having your blood tested for amyloid, go to Synpatek Labs for further instructions. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

  6. Apr 30

    White Amyloid Clots: Spike Protein Gone Wild

    Since the rollout of COVID shots in 2021, embalmers worldwide have reported a startling new phenomenon: unusual white, fibrous clots unlike any seen in decades of practice. These rubbery, calamari-like structures, often solid and stretchy, have appeared in 20-30% of corpses according to multiple surveys, primarily in individuals who received mRNA vaccines. Retired U.S. Air Force Major Tom Haviland, a data analyst and engineer, has become a leading voice documenting this issue after his own professional stand against vaccine mandates. Haviland, fired in 2021 from his $165,000 defense contracting role at Wright-Patterson Air Force Base for refusing the experimental mRNA shot, turned his analytical skills toward this mystery. Inspired by the 2022 documentary Died Suddenly, he contacted the Ohio Embalmers Association. Vice President Woody Wilson confirmed seeing the clots, corroborating accounts from embalmers who first noticed them roughly six months after vaccine deployment. Haviland and collaborator Laura Kasner launched global surveys of embalmers from 2022 to 2025. Results consistently showed 66-83% of respondents observing these clots in 20-30% of cases, with sharp increases in the 36-50 age group—aligning with excess mortality and disability data from analysts like Edward Dowd. Scientific teams, including Australian organic chemist Greg Harrison, have analyzed the clots using advanced techniques. Normal clotting involves fibrinogen converting to fibrin in balanced alpha, beta, and gamma chains, forming smooth, plasmin-degradable structures. These abnormal clots show a distorted 9:4:1 ratio, with high phosphorus, sulfur, and sometimes tin, low iron, magnesium, and potassium. Researchers hypothesize that spike protein—whether from infection or vaccine—and phospholipid nanoparticles phosphorylate and hijack fibrinogen, creating misfolded, amyloid-like polymers resistant to breakdown. Thioflavin T staining lights them up green under UV, confirming amyloid properties. Scanning electron microscopy reveals twisted, nodular fibers unlike normal “spaghetti-like” fibrin. Alarmingly, these clots appear not only in corpses but in living patients. Endovascular specialist Dr. Mahana Basheeret reported extracting them via catheter from legs, hearts, and other vessels in his Jacksonville cath lab. Similar reports from a UK whistleblower describe 3-10 such clots weekly, almost exclusively in vaccinated individuals, with severity increasing by dose count. Standard clot-busters like tPA fail; physical removal is required. Radiologists struggle to detect them as they mold to vessel walls. Microclots resembling “coffee grounds” also clog capillaries, impairing oxygen exchange.Official response has been minimal. Haviland shared survey data with FDA, CDC, and NIH annually since 2023, including before an advisory meeting, yet received no substantive action. Some doctors faced pressure to cease communication. Funeral associations largely remain silent, despite member concerns. Patient surveys (over 1,400 responses) mirror CDC V-safe data, showing post-2021 surges in leg, lung, brain, and heart clots. This vascular amyloidosis represents a visible, testable signal amid broader debates on vaccine side effects. While spike from infection may contribute in rare cases, persistence of mRNA-driven production offers a plausible driver for ongoing cases years later. Protocols like nattokinase, bromelain, and curcumin aim to address spike, with advanced filtration showing promise. As embalmers continue annual conventions and data collection, independent science must prioritize rigorous autopsy, imaging, and blood supply studies. Transparency and further investigation are essential to understand and mitigate this persistent issue. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

  7. Apr 23

    Peptides and Hormones: Hype vs Science

    Dr. Terri DeNeui, DNP, APRN, ACNP-BC, founder of Evexias and a leading expert in peptide and hormone therapies, discusses regulatory challenges with peptides and the importance of clinical supervision. Insulin and GLP-1 agonists are peptides with an established role in medicine. Now we are seeing broader applications of peptides used for inflammation, autoimmune conditions, muscle preservation, sleep, and tissue repair. The FDA’s 2022 decision to remove several peptides from the compounding safety list disrupted access for patients and clinicians. This shift pushed many toward gray-market sources, often labeled “research only,” raising serious safety concerns regarding purity, potency, and sourcing. Recent enforcement actions have shut down non-compliant suppliers shipping across state lines. DeNeui emphasizes that reputable compounding pharmacies adhering to FDA-inspected facilities and good manufacturing practices remain viable in certain states, but patients should avoid unverified online vendors. Underground products lack proper testing and clinician oversight, posing risks of contamination or inconsistent dosing. Growth hormone-stimulating peptides like CJC-1295 and ipamorelin attract teenagers via social media for muscle building and performance. DeNeui strongly cautions against this. Healthy adolescents with normal growth and puberty do not need them; exogenous interference can disrupt natural hormone balance, potentially stunting growth, elevating prolactin (causing gynecomastia), or causing pituitary issues. These compounds are better suited for age-related sarcopenia, injury recovery (e.g., Lisfranc fractures under medical supervision), or immune support in adults via peptides like Thymosin Alpha-1 and BPC-157. Proper cycling and clinician guidance are essential, as peptides act briefly and require tailored protocols. GLP-1 medications demonstrate strong efficacy for obesity and type 2 diabetes but demand careful management. Compounded versions are more affordable and allow micro-dosing to minimize side effects, though muscle loss remains a concern—up to 40% of weight lost can be lean mass without adequate protein and monitoring. Adverse events, including rare severe cases like pancreatitis, underscore the need for baseline assessments and experienced providers. DeNeui favors starting with semaglutide or tirzepatide from trusted sources. Hormone replacement, particularly subcutaneous bioidentical pellets (estrogen and testosterone), offers sustained release for three to six months. Unlike synthetic options such as Premarin (derived from mare urine), bioidentical or biosimilar hormones more closely mimic the body’s molecules. Pellet hormone therapy, used since the 1930s, supports mood, libido, energy, muscle maintenance, and overall quality of life, especially as testosterone declines in women post-childbearing. Progesterone is typically taken orally and necessary when taking estrogen to protect the uterus. Individual dosing accounts for age, activity, and hormone levels; side effects like unwanted hair growth are manageable. Urine metabolite testing (e.g., DUTCH) and GI mapping provide deeper insights into hormone processing and gut health, which influences conditions like PCOS, endometriosis, and fibroids. Both peptides and hormones offer powerful tools when used responsibly under trained clinicians. They are not shortcuts for lifestyle deficits but complements to nutrition, sleep, exercise, and stress management. As regulation evolves and research advances, prioritizing safety, evidence, and personalized care will maximize benefits while minimizing risks. Professional guidance remains non-negotiable for these potent therapies. Follow Terri DeNeui on X and learn more with her book “Hormone Havoc.” Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

    Peptides and Hormones: Hype vs Science

  8. Apr 22

    Blood Contamination Crisis: mRNA Shots and the Fight for Safe Transfusions

    The rollout of modified mRNA COVID-19 shots raises profound questions about long-term safety, including their potential persistence in the body and impact on the blood supply. Many individuals, particularly those unvaccinated or concerned about adverse reactions, now seek greater control over blood transfusions during planned surgeries or emergencies. Organizations like Safe Blood address this by matching recipients with donors who share similar vaccination status preferences, reviving practices once considered routine and noncontroversial. Safe Blood, founded in September 2021 by George Della Pietra in Switzerland, operates internationally with a strong U.S. presence across all 50 states. Vice President Clinton Ohlers, who heads media relations, explains that the group facilitates directed donations—where friends, family, or community members donate specifically for a patient—and supports autologous donations, in which patients donate their own blood in advance when time allows the body to regenerate red blood cells. This service proves especially vital when patients require multiple units for complex procedures like C-sections, aneurysm repairs, or cancer surgeries, exceeding what one person can safely provide alone. Concerns stem from early observations by European naturopaths and doctors who examined blood under magnification and noted anomalies in vaccinated individuals, sometimes resembling patterns seen in late-stage cancer patients, even among those without symptoms. These findings coincided with a reported 522% increase in blood-related illness claims in the UK from 2021 to 2022. While mainstream health authorities maintain that mRNA shots do not transmit via blood and that vaccinated donors pose no added risk, questions persist about lingering spike protein, potential DNA fragments, and biodistribution effects documented in some studies. A high-profile case involved a Texas patient at Baylor St. Luke’s whose wife—a universal donor—and friends were denied the opportunity to donate directed blood for his surgery. The hospital also resisted autologous donation despite sufficient lead time. Such denials highlight tensions between patient autonomy and institutional policies. The FDA issued guidance on October 23, 2023, cautioning that directed donations based on characteristics like vaccination status lack scientific support and may carry higher infectious disease risks than the general supply. Critics argue this relies on a 2013 Dorsey et al. study from an earlier era dominated by AIDS-related fears. That study initially showed higher infection markers in directed donations (often from first-time donors), but after adjusting for repeat versus new donors, the risk difference largely disappeared or even favored directed donations in some metrics. Opponents claim the FDA’s interpretation misrepresents the data to discourage patient choice, echoing past controversies over information suppression during the pandemic. The U.S. blood industry generates substantial revenue—estimated in the tens of billions annually—and the country exports a significant portion of plasma-derived products, accounting for roughly 2.65% of total exports and supplying about 70% of global needs in some categories. Blood banks often separate whole blood into components (packed red cells, platelets, plasma) for efficiency and reformulate as needed, a process that may generate more revenue than simple directed whole-blood transfers. Large organizations like the American Red Cross and others have opposed legislation protecting directed and autologous donations, citing supply chain concerns and invoking the FDA statement. Hospitals contract exclusively with one blood bank, creating bottlenecks when policies conflict. In response, over a dozen states have introduced bills to safeguard patient rights to autologous or directed donations and, in some cases, require labeling or separation of blood by donor vaccination status. Idaho advanced such legislation with near-unanimous support after testimony revealed local barriers, including denials even for autologous blood. Similar efforts in Texas nearly passed but faced procedural hurdles, while bills in Tennessee, Kentucky, and elsewhere continue. Proponents emphasize that one’s own blood or that from known healthy donors was historically the safest option and should not suddenly become restricted. They also highlight alternatives like Cell Saver technology, which recycles a patient’s own blood during surgery (common in open-heart procedures), though hospitals rarely offer it proactively. Demand for Safe Blood’s matching services is rising, driven by resistance from hospitals and blood banks. The organization does not collect or store blood itself to avoid heavy regulation; instead, it connects compatible donors and recipients for timely, fresh transfers coordinated through physicians and hospital blood banks. Membership is open on a sliding scale, with donor volunteers (unvaccinated individuals willing to help) providing critical support at no cost. Ultimately, this debate transcends blood logistics. It concerns medical freedom, transparency, and the right to informed consent in an era of novel biotechnologies whose full effects remain under study. While regulatory bodies assert the blood supply’s safety based on standard infectious disease screening (HIV, hepatitis, etc.), growing patient advocacy seeks empirical verification and choice—especially in non-emergencies. As states deliberate legislation, the core principle endures: the safest blood is often one’s own or from trusted sources, and policies should prioritize patient well-being over institutional convenience or industry flow. Safe Blood and similar initiatives represent a grassroots effort to restore that autonomy, ensuring future generations inherit a blood supply that respects individual risk assessments. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

    Blood Contamination Crisis: mRNA Shots and the Fight for Safe Transfusions
See All (46)

Ratings & Reviews

5
out of 5
2 Ratings

About

In-depth interviews with whistleblowers, frontline physicians, veterans, and health freedom advocates who challenge mainstream medical narratives. Episodes explore vaccine safety, bodily autonomy, decentralized healthcare, and critiques of corporate medicine, often drawing from Dr. Bowden's own experiences treating thousands of COVID patients successfully and her legal battles against mandates and censorship. drbowden.substack.com

Information

  • Creator
    Transparency, informed consent, and patient empowerment
  • Years Active
    2026
  • Episodes
    46
  • Rating
    Clean
  • Copyright
    © Mary Talley Bowden MD
  • Show Website
    On Call with Dr. Mary Talley Bowden

You Might Also Like